GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Torii Pharmaceutical Co Ltd (TSE:4551) » Definitions » 3-Year Dividend Growth Rate

Torii Pharmaceutical Co (TSE:4551) 3-Year Dividend Growth Rate : 35.70% (As of Mar. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Torii Pharmaceutical Co 3-Year Dividend Growth Rate?

Torii Pharmaceutical Co's Dividends per Share for the three months ended in Mar. 2024 was 円0.00.

The historical rank and industry rank for Torii Pharmaceutical Co's 3-Year Dividend Growth Rate or its related term are showing as below:

TSE:4551' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 3.6   Med: 10.8   Max: 39.7
Current: 35.7

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Torii Pharmaceutical Co was 39.70% per year. The lowest was 3.60% per year. And the median was 10.80% per year.

TSE:4551's 3-Year Dividend Growth Rate is ranked better than
83.44% of 320 companies
in the Drug Manufacturers industry
Industry Median: 9.8 vs TSE:4551: 35.70

During the past 12 months, Torii Pharmaceutical Co's average Dividends Per Share Growth Rate was 20.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 35.70% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 21.40% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 8.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Torii Pharmaceutical Co's Dividend Payout Ratio for the three months ended in Mar. 2024 was 0.00. As of today, Torii Pharmaceutical Co's Dividend Yield % is 3.03%.

Warning Sign:

Torii Pharmaceutical Co Ltd stock dividend yield is close to 1-year low.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Torii Pharmaceutical Co's 3-Year Dividend Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Torii Pharmaceutical Co's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Torii Pharmaceutical Co's 3-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Torii Pharmaceutical Co's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Torii Pharmaceutical Co's 3-Year Dividend Growth Rate falls into.



Torii Pharmaceutical Co 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Torii Pharmaceutical Co  (TSE:4551) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Torii Pharmaceutical Co's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2024 )/ EPS without NRI (Q: Mar. 2024 )
=0/ 37.93
=0.00

During the past 13 years, the highest Dividend Payout Ratio of Torii Pharmaceutical Co was 1.10. The lowest was 0.28. And the median was 0.44.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Torii Pharmaceutical Co Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
JPY 70.0000002023-12-282023-12-312024-03-28Cash Dividendsemi-annuallyJPY:JPY 1.000000
JPY 50.0000002023-06-292023-06-302023-09-05Cash Dividendsemi-annuallyJPY:JPY 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Torii Pharmaceutical Co's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=120/3930.00
=3.05 %

Current Share Price is 円3930.00.
Torii Pharmaceutical Co's Dividends per Share for the trailing twelve months (TTM) ended in Today is 円120.

During the past 13 years, the highest Dividend Yield of Torii Pharmaceutical Co was 3.67%. The lowest was 0.60%. And the median was 1.67%.

Warning Sign:

Torii Pharmaceutical Co Ltd stock dividend yield is close to 1-year low.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Torii Pharmaceutical Co 3-Year Dividend Growth Rate Related Terms>


Torii Pharmaceutical Co (TSE:4551) Business Description

Traded in Other Exchanges
N/A
Address
Torii Nihonbashi Buildingg, 4-1, Nihonbashi-Honcho, 3-chome, Chuo-ku, Tokyo, JPN, 103-8439
Torii Pharmaceutical Co Ltd is a major drug manufacturing company. The company utilizes strategic partnerships with other pharmaceutical companies in order to combine research and marketing functions. Torii's key therapeutic areas include renal diseases, hemodialysis, HIV, skin diseases, and allergens. The vast majority of the company's net mainstay product sales are derived from the renal diseases and hemodialysis operations, followed by HIV. Torii's places its strategic focus on prompt market penetration and expansion of new products as well as maximizing values of mainstay products in each priority area.

Torii Pharmaceutical Co (TSE:4551) Headlines

No Headlines